Predict your next investment

Private Equity
riversidepartners.com

See what CB Insights has to offer

Investments

25

Portfolio Exits

17

Funds

6

Partners & Customers

2

Service Providers

1

About Riverside Partners

Founded in 1989, Riverside Partners is a private equity financing firm.

Riverside Partners Headquarter Location

One Exeter Plaza

Boston, Massachusetts, 02116,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Riverside Partners News

Riverside Partners' Portfolio Company Loftware Acquires PRISYM ID

Jan 11, 2022

News provided by Share this article Share this article BOSTON, Jan. 11, 2022 /PRNewswire/ -- Loftware, Inc. ("Loftware" or the "Company"), the largest global software company specializing in Enterprise Labeling and Artwork Management solutions, today announced that it has acquired PRISYM ID, a leading provider of regulated content and label management solutions with a focus on clinical trials, medical device and pharmaceutical labeling. Loftware is a portfolio company of Riverside Partners, a Boston-based private equity firm. Over the course of Riverside Partners' investment in Loftware, the Company has grown substantially, expanding both its software solutions offering and global presence. The acquisition of PRISYM ID is the latest chapter in this transformation and furthers Loftware's long-standing commitment to the medical device and pharmaceutical industries. The acquisition enhances Loftware's end-to-end cloud-based labeling platform by adding advanced clinical trial labeling and regulated content management capabilities. "We are thrilled to support the combination of Loftware and PRISYM ID," said David Belluck, a General Partner at Riverside Partners. "Riverside specializes in investing in both middle market healthcare and technology businesses. The goal in bringing Loftware and PRISYM ID together is to create an industry leader serving key healthcare end markets that will provide best-in-class software solutions for customers. The acquisition provides additional scale and scope for the business, and further strengthens Loftware's industry leadership." The union furthers Loftware's long-standing commitment to medical device and pharmaceutical customers and strengthens the Company's ability to meet labeling complexities and evolving regulatory demands. The need to improve agility, manufacturing, and distribution in support of patient safety and healthcare outcomes has never been more vital as COVID-19 has amplified the challenges in medical device and pharmaceutical supply chains. "This acquisition builds on Loftware's and PRISYM ID's experience and unites the best talent in the medical device and pharmaceutical labeling industry today. Combined, we serve many of the largest global companies with solutions, services and support that are vital to managing labeling complexities and regulatory requirements," stated Loftware President and CEO, Robert O'Connor Jr. "PRISYM ID is a pioneer in clinical trials labeling and delivers solutions that are purpose built for managing the nuances of this space. We will enable customers to tackle the complex challenges around clinical trial labeling and help them with the ability to quickly and efficiently complete trials," he added. Building on PRISYM ID's industry focus, Loftware will offer customers new levels of innovation to help enable compliance through accurate, validation-ready labeling solutions and regulated product content, while also growing the Loftware platform and offering more services to these strategic markets. The platform empowers companies to optimize continuity, improve agility and enable traceability as they're faced with new and ensuing challenges around today's complex supply chain, which has placed extra emphasis on the importance of labeling. About Loftware Loftware is the world's largest cloud-based Enterprise Labeling and Artwork Management provider, offering an end-to-end labeling solution platform for companies of all sizes. Maintaining a global presence with offices in US, UK, Germany, Slovenia, China, and Singapore, Loftware boasts over 35 years of expertise in solving labeling challenges. Loftware helps companies improve accuracy, traceability and compliance while improving the quality, speed, and efficiency of their labeling. As the leading global provider of Enterprise Labeling and Artwork Management solutions, Loftware enables supply chain agility, supports evolving regulations, and optimizes business operations for a wide range of industries including automotive, chemicals, consumer products, electronics, food & beverage, manufacturing, medical device, pharmaceuticals, retail and apparel. About PRISYM ID PRISYM ID provides regulated content and label management solutions designed specifically for life science companies and medical device manufacturers, improving patient safety and health outcomes whilst ensuring regulatory compliance. PRISYM ID's unique products and technologies are used to assure compliance globally, for 10 million+ medical device, clinical trials and pharmaceutical products annually. About Riverside Partners Founded in 1989, Riverside Partners is a middle market private equity firm with total capital commitments of $1.6 billion raised since inception. The firm focuses on growth-oriented companies in the healthcare and technology industries. Riverside Partners is particularly experienced at partnering with founders, owners, and management teams and brings substantial domain expertise and operating experience to its portfolio companies. For more information, visit www.riversidepartners.com . SOURCE Riverside Partners

Riverside Partners Investments

25 Investments

Riverside Partners has made 25 investments. Their latest investment was in Convergence Networks as part of their Private Equity on December 12, 2020.

CBI Logo

Riverside Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/2/2020

Private Equity

Convergence Networks

Yes

1

10/22/2016

Private Equity - III

BioAgilytix Labs

$2M

No

1

5/3/2016

Private Equity - II

BioAgilytix Labs

$6.98M

No

1

7/31/2015

Private Equity

Subscribe to see more

Subscribe to see more

10

4/3/2015

Private Equity

Subscribe to see more

Subscribe to see more

10

Date

12/2/2020

10/22/2016

5/3/2016

7/31/2015

4/3/2015

Round

Private Equity

Private Equity - III

Private Equity - II

Private Equity

Private Equity

Company

Convergence Networks

BioAgilytix Labs

BioAgilytix Labs

Subscribe to see more

Subscribe to see more

Amount

$2M

$6.98M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Riverside Partners Portfolio Exits

17 Portfolio Exits

Riverside Partners has 17 portfolio exits. Their latest portfolio exit was R&D Altanova on October 28, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/28/2021

Acquired

5

12/1/2020

Merger

2

5/25/2020

IPO

$99M

1

11/19/2019

Merger

Subscribe to see more

Subscribe to see more

10

3/26/2019

Merger

Subscribe to see more

Subscribe to see more

10

Date

10/28/2021

12/1/2020

5/25/2020

11/19/2019

3/26/2019

Exit

Acquired

Merger

IPO

Merger

Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

2

1

10

10

Riverside Partners Acquisitions

27 Acquisitions

Riverside Partners acquired 27 companies. Their latest acquisition was Syner-G Pharma Consulting on October 29, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/29/2020

$99M

Acq - Fin

2

8/16/2019

$99M

Acq - Fin

2

5/14/2019

Other

$99M

$0.95M

Acq - Fin

3

3/26/2019

Subscribe to see more

$99M

Subscribe to see more

10

9/13/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/29/2020

8/16/2019

5/14/2019

3/26/2019

9/13/2017

Investment Stage

Other

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$0.95M

Note

Acq - Fin

Acq - Fin

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

2

2

3

10

10

Riverside Partners Fund History

6 Fund Histories

Riverside Partners has 6 funds, including Riverside Fund V LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/13/2012

Riverside Fund V LP

Buyouts & Acquisitions

Closed

$561M

1

1/25/2010

Riverside Fund IV LP

Subscribe to see more

Subscribe to see more

$99M

10

5/1/2006

Riverside Fund III LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1998

Riverside Fund II LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1989

Riverside Fund I LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

5/13/2012

1/25/2010

5/1/2006

12/31/1998

12/31/1989

Fund

Riverside Fund V LP

Riverside Fund IV LP

Riverside Fund III LP

Riverside Fund II LP

Riverside Fund I LP

Fund Type

Buyouts & Acquisitions

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$561M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Riverside Partners Partners & Customers

2 Partners and customers

Riverside Partners has 2 strategic partners and customers. Riverside Partners recently partnered with Barings Asset Management on February 2, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

2/27/2017

Partner

Barings Asset Management

United States

Barings Provides Senior Credit Facilities to Support Riverside Partners’ Acquisition of Medical Reimbursements of America.

`` Riverside Partners is pleased to partner with Barings on our investment in Medical Reimbursements of America , '' said Max Osofsky , general partner at Riverside Partners .

1

6/12/2015

Partner

Contractor Management Services

United States

Subscribe to see more

Subscribe to see more

10

Date

2/27/2017

6/12/2015

Type

Partner

Partner

Business Partner

Barings Asset Management

Contractor Management Services

Country

United States

United States

News Snippet

Barings Provides Senior Credit Facilities to Support Riverside Partners’ Acquisition of Medical Reimbursements of America.

`` Riverside Partners is pleased to partner with Barings on our investment in Medical Reimbursements of America , '' said Max Osofsky , general partner at Riverside Partners .

Subscribe to see more

Subscribe to see more

Sources

1

10

Riverside Partners Service Providers

1 Service Provider

Riverside Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - Fin

Counsel

Financial Advisor

Service Provider

Associated Rounds

Acq - Fin

Provider Type

Counsel

Service Type

Financial Advisor

Partnership data by VentureSource

Riverside Partners Team

10 Team Members

Riverside Partners has 10 team members, including current Chief Financial Officer, Kevin Sullivan.

Name

Work History

Title

Status

Kevin Sullivan

Chief Financial Officer

Current

David Belluck

General Partner

Current

Philip Borden

General Partner

Current

Frank Do

General Partner

Current

Brian Guthrie

General Partner

Current

Name

Kevin Sullivan

David Belluck

Philip Borden

Frank Do

Brian Guthrie

Work History

Title

Chief Financial Officer

General Partner

General Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.